Lesions located inside and beyond the bowel demonstrate the extent of disease in a fused PET/CT image acquired at the National Cancer Center Hospital East in Kashiwa City, Japan, using an eight-slice Discovery LS from GE Healthcare. The volumetric scan fuses data acquired during tumor uptake of FDG and contrast-enhanced CT. Such data sets typically host the reconstruction of transaxial, coronal, and sagittal slices, but, in this case, the data were fashioned into a volumetric image that served as a guide for surgical resection of the tumor. Experimental software integrated PET data regarding the tumor and CT data representing vasculature, selected soft tissue, and bone. GE has developed a commercial version, the Advantage Windows Volume Viewer Plus. (Provided by GE Healthcare)
Lesions located inside and beyond the bowel demonstrate the extent of disease in a fused PET/CT image acquired at the National Cancer Center Hospital East in Kashiwa City, Japan, using an eight-slice Discovery LS from GE Healthcare. The volumetric scan fuses data acquired during tumor uptake of FDG and contrast-enhanced CT. Such data sets typically host the reconstruction of transaxial, coronal, and sagittal slices, but, in this case, the data were fashioned into a volumetric image that served as a guide for surgical resection of the tumor. Experimental software integrated PET data regarding the tumor and CT data representing vasculature, selected soft tissue, and bone. GE has developed a commercial version, the Advantage Windows Volume Viewer Plus. (Provided by GE Healthcare)
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.